Fanny Yan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Redwood Hwy Frontage Rd Ste 110, Mill Valley, CA 94941 Phone: 415-360-9020 |
Liesl Reyes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Redwood Hwy Frontage Rd Ste 110, Mill Valley, CA 94941 Phone: 415-360-9020 |
Khang Tu Truong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 E.blithedale Ave, Mill Valley, CA 94941 Phone: 415-388-2546 Fax: 415-388-1326 |
Jennifer Kichinko Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Redwood Hwy Frontage Rd Ste 100, Mill Valley, CA 94941 Phone: 415-360-9020 |
Dr. Stephanie Erin Thomas, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 227 Shoreline Hwy, Mill Valley, CA 94941 Phone: 415-380-8402 Fax: 415-380-9064 |
Amy Malmquist Canter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Camino Alto, Mill Valley, CA 94941 Phone: 415-388-6216 |
Brian Lee, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 227 Shoreline Hwy, Mill Valley, CA 94941 Phone: 415-380-8402 |
Ismail Abdolahi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Camino Alto, Mill Valley, CA 94941 Phone: 808-494-8960 |
Dr. Margaret Van Veen Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Camino Alto, Mill Valley, CA 94941 Phone: 415-388-2701 Fax: 415-388-7142 |
Jeffrey Thuan Le Lien Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 227 Shoreline Hwy, Mill Valley, CA 94941 Phone: 415-380-8402 |
Robin Toschi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Camino Alto, Mill Valley, CA 94941 Phone: 415-388-2701 |
Natalie Alyssa Milton, DR Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 759 E Blithedale Ave, Mill Valley, CA 94941 Phone: 415-389-8891 |
Christine Lin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Redwood Hwy Frontage Rd Ste 110, Mill Valley, CA 94941 Phone: 415-360-9020 Fax: 415-360-9021 |
Bryce Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 E Blithedale Ave, Mill Valley, CA 94941 Phone: 415-388-2546 |
Minh Cam Dang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 227 Shoreline Hwy, Mill Valley, CA 94941 Phone: 415-380-8402 |
Ronda Lowe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 759 E Blithedale Ave, Mill Valley, CA 94941 Phone: 415-389-8891 |
News Archive
The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services Biomedical Research and Development Authority (BARDA) has canceled its request for proposal (RFP) for Recombinant Protective Antigen Anthrax Vaccine for the Strategic National Stockpile (RFP BARDA 08-15).
The HIV Medicine Association of the Infectious Diseases Society of America has updated its HIV care guidelines to reflect the fact that people with HIV are now living normal life spans, and their physicians need to focus on preventive care, including screening for high cholesterol, diabetes and osteoporosis.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
› Verified 7 days ago